ALLOX closes $10.5M seed financing to scale drug discovery platform

Biotechnology company ALLOX has raised $10.5 million in a seed funding round to expand its drug discovery platform and advance its internal development programmes. The round was led by Asabys through its Sabadell Asabys II fund, with participation from CDTI through SICC Innvierte and the Institut Català de Finances (ICF). ALLOX is developing a drug discovery platform that combines high-throughput genetics, experimental biology and artificial intelligence to identify previously unexplored opportu